OHSU

Technology Transfer and Business Development

TTBD partners with industry to collaborate and conduct research, license promising discoveries and intellectual property, and launch companies based on OHSU technologies. 

Featured Technology

David Kabat

David Kabat, PhD

Antiviral Drug Discovery for AIDS: The HIV-1 Vif Protein

Virion infectivity factor (Vif) is a regulatory protein produced by lentiviruses. Targeting the human DNA-editing enzyme, APOBEC3G, a host defense factor that inhibits viral replication, Vif binds to APOBEC3G and prevents it from functioning properly in host defense. Therefore, inhibition of Vif-mediated degradation of APOBEC3G is a new avenue for anti-HIV drug development. 
Learn more about this technology.


Industry Collaboration Opportunities

Eli Lilly PD2 Initiative
Eli Lilly has created the Phenotypic Drug Discovery (PD2) Initiative as one mechanism to collaborate with academic institutes. The initiative provides a means for screening potentially therapeutic compounds developed at academic research centers in Lilly's proprietary assay system. Lilly will screen compounds in a set of assay modules that include a primary phenotypic screening and secondary biochemical and cellular assays in the following areas:

  • Alzheimer's Disease (ApoE secretion)
  • Cancer  (anti-angiogenesis)
  • Cancer (cell cycle G2/M arrest)
  • Bone Formation (Wnt pathway)
  • Diabetes (insulin secretion)

Learn more about this opportunity from OHSU

More detailed information from Lilly

News & Announcements

August 12, 2010           
Oregon Innovation Showcase 2010 Date and Location Announced
Hosted by Innovate|Collaborate|Oregon and the Oregon Bioscience Association, The 2010 Innovation Showcase: The Design and Development of Medical Devices will feature presentations from Oregon's four premier research universities and local medical device companies for an afternoon of science, business, and networking on November 2, 2010 at the Oregon Convention Center.

May 21, 2010           
IRS Issues Guidelines for $1B Tax Credit-or-Cash Program Aimed at Startups
On May 21, 2010, the U.S. Department of the Treasury announced the guidelines for applying for the new Therapeutic Discovery Project Program created by the Affordable Care Act.  The program will provide tax credits and grants to small firms that show significant potential to produce new and cost-saving therapies, support good jobs and increase U.S. competitiveness. 
Read more

More News & Announcements